Chapel Hill, NC, United States of America

Luis Molina

This inventor holds 1 USPTO granted patent. Top assignee: Glaxo Wellcome Inc.. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Luis Molina. Retrieved from https://idiyas.com/inventor/luis-molina-sloqhq0f

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Luis Molina

Introduction

Luis Molina is an accomplished inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of medical research, particularly in the area of airway health. His work focuses on developing solutions that can improve patient outcomes and enhance therapeutic options.

Latest Patents

Luis Molina holds a patent for "Nitric oxide synthase inhibitors for inhibiting the production of airway." This innovative approach aims to address critical issues related to airway conditions, showcasing his commitment to advancing medical science. He has 1 patent to his name, reflecting his dedication to innovation.

Career Highlights

Molina is currently employed at Glaxo Wellcome Inc., a leading pharmaceutical company known for its research and development in healthcare. His role at the company allows him to collaborate with other experts in the field and contribute to groundbreaking projects that can change lives.

Collaborations

One of his notable coworkers is Thomas P. Zimmerman, with whom he has likely shared insights and expertise in their respective areas of research. Their collaboration exemplifies the importance of teamwork in driving innovation and achieving significant advancements in medical technology.

Conclusion

Luis Molina's work as an inventor highlights the vital role of innovation in healthcare. His patent on nitric oxide synthase inhibitors demonstrates his commitment to improving airway health. Through his career at Glaxo Wellcome Inc., he continues to make strides in medical research, contributing to a healthier future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…